Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robotic glove lends a hand: small trial tests daily life support for weak grip

NCT ID NCT06033027

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a soft robotic glove called Carbonhand can help people with hand weakness from injury or nerve conditions perform daily activities at home. Five participants will use the glove for six weeks while researchers measure arm activity, grip strength, and well-being. It is a very small early study focused on understanding real-world use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Carbonhand soft-robotic glove
What this could lead to
If it works, this could point toward a practical tool to help people with hand weakness perform everyday activities more easily.
What could go wrong
This is a very small early study with only 5 participants, so results may not apply to everyone. The glove may not provide meaningful benefit or may be inconvenient for daily use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 90 years * Experience difficulties in performing ADL due to hand function limitations as a result of trauma-related injury or neurologic disorder * Being in a chronic/stable phase of disease as judged by their physician * Able to activate the soft-robotic glove by generating pressure on finger/palm sensors when grasping an object * Ability to relax an active grip * Sufficient cognitive status to understand two-step instructions * Having (corrected to) normal vision * Able to provide written informed consent * Living independently Exclusion Criteria: * Severe sensory problems of the most-affected hand * Severe acute pain of the most-affected hand * Wounds on the hands that can provide a problem when using the glove * Severe contractures limiting passive range of motion to the extent that the glove can't be donned/activated comfortably * Co-morbidities limiting functional use/performance of the arms and/or hands * Severe spasticity of the hand (≥2 points on Ashworth Scale) * Severe proximal weakness (MRC shoulder elevation\<4) * Used the Carbonhand system in the past 3 months * Participation in other studies that can affect functional performance of the arm/hand * Receiving arm-/hand function therapy during the course of the study * Insufficient digital literacy to conduct video calls * Insufficient knowledge of the Dutch or English language to understand the purpose or methods of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurologic disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Roessingh Research and Development

    RECRUITING

    Enschede, Overijssel, 7522AH, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.